Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00004217
First received: January 28, 2000
Last updated: March 5, 2015
Last verified: March 2015